2-trifluoromethyl-7-substitute-6,7,8,9-tetrahydro-[5H]-benzocycl

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

5142395, 514255, 514318, 514396, 514427, 514510, 514520, 514567, 514569, 514617, 514622, 514625, 514657, 514717, 514729, 544106, 544403, 546205, 548335, 548346, 558426, 560 35, 560 38, 560 43, 560 65, 560 73, 560105, 560107, 560250, 560255, 562440, 562449, 562452, 562456, 564 86, 564179, 564184, 564270, 564428, 564625, 568661, 568808, A61K 31045, A61K 31075, A61K 31135, A61K 31155

Patent

active

050792458

ABSTRACT:
The compounds 2-trifluoromethyl-7-substituted-6,7,8,9-tetrahydro-[5H]-benzocycloheptenes are disclosed and disclosed to be useful in the treatment of metabolic illnesses such as diabetes, obesity, and their complications. A perferred compound is 2-trifluoromethyl-7-amino-6,7,8,9-tetrahydro-[5H-benzocycloheptane.

REFERENCES:
patent: 3836534 (1974-09-01), Drukker et al.
patent: 4091115 (1978-05-01), Nedblec et al.
patent: 4128666 (1978-12-01), Bondinell et al.
patent: 4132737 (1979-01-01), Molloy
patent: 4177292 (1979-12-01), Nedelec et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-trifluoromethyl-7-substitute-6,7,8,9-tetrahydro-[5H]-benzocycl does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-trifluoromethyl-7-substitute-6,7,8,9-tetrahydro-[5H]-benzocycl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-trifluoromethyl-7-substitute-6,7,8,9-tetrahydro-[5H]-benzocycl will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-822711

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.